Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response

Journal of General Virology

Volumn 77, Issue 7, 1996, Pages 1537-1547

  Urban, M ^a   Klein, M ^a   Britt, W J ^b   Hassfurther E ^a   Mach, M ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; BACULOVIRUS; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMORAL IMMUNITY; INSECT; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; VIRUS IMMUNITY; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT;

EID: 0029993209     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-7-1537     Document Type: Article

References (50)

1. Adler, S. P., Starr, S. E., Plotkin, S. A., Hempfling, S. H., Buis, J., Manning, M. L. & Best, A. M. (1995). Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. Journal of Infectious Diseases 171, 26-32.
2. Andreoni, M., Faircloth, M., Vugler, L. & Britt, W. J. (1989). A rapid microneutralization assay for the measurement of neutralizing antibody reactive with human cytomegalovirus. Journal of Virological Methods 23, 157-167.
3. Baboonian, C., Blake, K., Booth, J. C. & Wiblin, C. N. (1989). Complement-independent neutralising monoclonal antibody with differential reactivity for strains of human cytomegalovirus. Journal of Medical Virology 29, 139-145.
4. Beninga, J., Kropff, B. & Mach, M. (1995). Comparative analysis of fourteen individual human cytomegalovirus proteins for helper T cell response. Journal of General Virology 76, 153-160.
5. Bogner, E., Reschke, M., Reis, B., Reis, E., Britt, W. & Radsak, K. (1992). Recognition of compartmentalized intracellular analogs of glycoprotein H of human cytomegalovirus. Archives of Virology 126, 67-80.
6. Britt, W. J. & Vugler, L. G. (1992). Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116). Journal of Virology 66, 6747-6754.
7. Britt, W. J., Vugler, L., Butfiloski, E. J. & Stephens, E. B. (1990). Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response. Journal of Virology 64, 1079-1085.
8. Browne, H., Baxter, V. & Minson, T. (1993). Analysis of protective immune responses to the glycoprotein H-glycoprotein L complex of herpes simplex virus type 1. Journal of General Virology 74, 2813-2817.
9. Chou, S. (1992). Molecular epidemiology of envelope glycoprotein H of human cytomegalovirus. Journal of Infectious Diseases 166, 604-607.
10. Chou, S. W. & Dennison, K. M. (1991). Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. Journal of Infectious Diseases 163, 1229-1234.
11. Cranage, M. P., Smith, G. L., Bell, S. E., Hart, H., Brown, C., Bankier, A. T., Tomlinson, P., Barrell, B. G. & Minson, T. C. (1988). Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H. Journal of Virology 62, 1416-1422.
12. Duus, K. M., Hatfield, C. & Grose, C. (1995). Cell surface expression and fusion by the varicella-zoster virus gH:gL glycoprotein complex: analysis by laser scanning confocal microscopy. Virology 210, 429-440.
13. Ehrlich, P. H., Moustafa, Z. A., Justice, J. C., Harfeldt, K. E. & Ostberg, L. (1988). Further characterization of the fate of human monoclonal antibodies in rhesus monkeys. Hybridoma 7, 385-395.
14. Foa-Tomasi, L., Avitabile, E., Boscaro, A., Brandimarti, R., Gualandri, R., Manservigi, R., Dall'Olio, F., Serafini-Cessi, F. & Fiume, G. C. (1991). Herpes simplex virus (HSV) glycoprotein H is partially processed in a cell line that expresses the glycoprotein and fully processed in cells infected with deletion or ts mutants in the known HSV glycoproteins. Virology 180, 474-482.
15. Forghani, B., Ni, L. & Grose, C. (1994). Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex. Virology 199, 458-462.
16. Forrester, A. J., Sullivan, V., Simmons, A., Blacklaws, B. A., Smith, G. L., Nash, A. A. & Minson, A. C. (1991). Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus. Journal of General Virology 72, 369-375.
17. Fowler, K. B., Stagno, S., Pass, R. F., Britt, W. J., Boll, T. J. & Alford, C. A. (1992). The outcome of congenital cytomegalovirus infection in relation to maternal antibody status [see comments]. New England Journal of Medicine 326, 663-667.
18. Ghiasi, H., Nesburn, A. B. & Wechsler, S. L. (1991). Cell surface expression of herpes simplex virus type 1 glycoprotein H in recombinant baculovirus-infected cells. Virology 185, 187-194.
19. Gompels, U. A. & Minson, A. C. (1989). Antigenic properties and cellular localization of herpes simplex virus glycoprotein H synthesized in a mammalian cell expression system. Journal of Virology 63, 4744-4755.
20. Goochee, C. F., Gramer, M. J., Andersen, D. C., Bahr, J. B. & Rasmussen, J. R. (1991). The oligosaccharides of glycoproteins: bioprocess factors affecting oligosaccharide structure and their effect on glycoprotein properties. Biotechnology N.Y. 9, 1347-1355.
21. Gretch, D. R., Kari, B., Gehrz, R. C. & Stinski, M. F. (1988). A multigene family encodes the human cytomegalovirus glycoprotein complex gcll (gp47-52 complex). Journal of Virology 62, 1956-1962.
22. Harlow, E. & Lane, D. (1988). Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
23. Ho, M. (1993). Cytomegalovirus. Biology and Infection. New York: Plenum.
24. Hutchinson, L., Browne, H., Wargent, V., Davis-Poynter, N., Primorac, S., Goldsmith, K., Minson, A. C. & Johnson, D. C. (1992). A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. Journal of Virology 66, 2240-2250.
25. Jonjic, S., Pavic, I., Polic, B., Crnkovic, I., Lucin, P. & Koszinowski, U. H. (1994). Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. Journal of Experimental Medicine 179, 1713-1717.
26. Kaye, J. F., Gompels, U. A. & Minson, A. C. (1992). Glycoprotein H of human cytomegalovirus (HCMV) forms a stable complex with the HCMV UL115 gene product. Journal of General Virology 73, 2693-2698.
27. Klupp, B. G., Baumeister, J., Karger, A., Visser, N. & Mettenleiter, T. C. (1994). Identification and characterization of a novel structural glycoprotein in pseudorabies virus, gL. Journal of Virology 68, 3868-3878.
28. Kohl, S. (1992). The role of antibody in herpes simplex virus infection in humans. Current Topics in Microbiology and Immunology 179, 75-88.
29. Kuroda, K., Geyer, H., Geyer, R., Doerfler, W. & Klenk, H. D. (1990). The oligosaccharides of influenza virus hemagglutinin expressed in insect cells by a baculovirus vector. Virology 174, 418-429.
30. Lehner, R., Stamminger, T. & Mach, M. (1991). Comparative sequence analysis of human cytomegalovirus strains. Journal of Clinical Microbiology 29, 2494-2502.
31. Liu, D. X., Gompels, U. A., Foa-Tomasi, L. & Campadelli-Fiume, G. (1993). Human herpesvirus-6 glycoprotein H and L homologs are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies. Virology 197, 12-22.
32. Luckow, V. A. & Summers, M. D. (1988). Signals important for high-level expression of foreign genes in Autographa californica nuclear polyhedrosis virus expression vectors. Virology 167, 56-71.
33. Marshall, G. S., Rabalais, G. P., Stout, G. G. & Waldeyer, S. L. (1992). Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity. Journal of Infectious Diseases 165, 381-384.
34. Rapp, M., Messerle, M., Lucin, P. & Koszinowski, U. H. (1993). In vivo protection studies with MCMV glycoproteins gB and gH expressed by vaccinia virus. In Multidisciplinary Approach to Understanding Cytomegalovirus Disease, pp. 327-332. Edited by S. Michelson & S. A. Plotkin. Amsterdam: Excerpta Medica.
35. Rasmussen, L. (1993). Progress in the development of a human cytomegalovirus glycoprotein subunit vaccine. In Multidisciplinary Approach to Understanding Cytomegalovirus Disease, pp. 311-320. Edited by S. Michelson & S. A. Plotkin. Amsterdam: Excerpta Medica.
36. Rasmussen, L. E., Nelson, R. M., Kelsall, D. C. & Merigan, T. C. (1984). Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus. Proceedings of the National Academy of Sciences, USA 81, 876-880.
37. Rasmussen, L., Matkin, C., Spaete, R., Pachl, C. & Merigan, T. C. (1991). Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans. Journal of Infectious Diseases 164, 835-842.
38. Reddehase, M. J., Mutter, W., Munch, K., Buhring, H. J. & Koszinowski, U. H. (1987). CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. Journal of Virology 61, 3102-3108.
39. Reusser, P., Riddell, S. R., Meyers, J. D. & Greenberg, P. D. (1991). Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78, 1373-1380.
40. Riddell, S. R. & Greenberg, P. D. (1994). Therapeutic reconstitution of human viral immunity by adoptive transfer of cytotoxic T lymphocyte clones. Current Topics in Microbiology and Immunology 189, 9-34.
41. Roberts, S. R., Ponce de-Leon, M., Cohen, G. H. & Eisenberg, R. J. (1991). Analysis of the intracellular maturation of the herpes simplex virus type 1 glycoprotein gH in infected and transfected cells. Virology 184, 609-624.
42. Roy, D. M., Grundy, J. E. & Emery, V. C. (1993). Sequence variation within neutralizing epitopes of the envelope glycoprotein B of human cytomegalovirus: comparison of isolates from renal transplant recipients and AIDS patients. Journal of General Virology 74, 2499-2505.
43. Simpson, J. A., Chow, J. C., Baker, J., Avdalovic, N., Yuan, S., Au, D., Co, M. S., Vasquez, M., Britt, W. J. & Coelingh, K. L. (1993). Neutralizing monoclonal antibodies that distinguish three antigenic sites on human cytomegalovirus glycoprotein H have conformationally distinct binding sites. Journal of Virology 67, 489-496.
44. Spaete, R. R., Perot, K., Scott, P. I., Nelson, J. A., Stinski, M. F. & Pachl, C. (1993). Coexpression of truncated human cytomegalovirus gH with the UL115 gene product or the truncated human fibroblast growth factor receptor results in transport of gH to the cell surface. Virology 193, 853-861.
45. Spaete, R. R., Gehrz, R. C. & Landini, M. P. (1994). Human cytomegalovirus structural proteins. Journal of General Virology 75, 3287-3308.
46. Urban, M., Britt, W. & Mach, M. (1992). The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific. Journal of Virology 66, 1303-1311.
47. Urban, M., Winkler, T., Landini, M. P., Britt, W. & Mach, M. (1994). Epitope-specific distribution of IgG subclasses against antigenic domains on glycoproteins of human cytomegalovirus. Journal of Infectious Diseases 169, 83-90.
48. Utz, U., Britt, W., Vugler, L. & Mach, M. (1989). Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus. Journal of Virology 63, 1995-2001.
49. Wells, D. E., Vugler, L. G. & Britt, W. J. (1990). Structural and immunological characterization of human cytomegalovirus gp55-116 (gB) expressed in insect cells. Journal of General Virology 71, 873-880.
50. Yaswen, L. R., Stephens, E. B., Davenport, L. C. & Hutt-Fletcher, L. M. (1993). Epstein-Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein. Virology 195, 387-396.